[EATG Global HIV News daily digest] Digest #192-2009

[EATG Global HIV News daily digest]

Global HIV News Daily Digest

Copied as fair use  -  Ana  -






  




Latest Headlines




  ViiV vows joint venture will help fight HIV
  Pharma Industry Friday 06 November 2009
					
  
The new head of the pioneering HIV joint venture between
GlaxoSmithKline and Pfizer predicts his company can operate for at
least five years without fresh funding from its shareholders. 
  SOURCE:
FT.com




  GenVec signs new contract to support HIV and influenza vaccine development
  Prevention Friday 06 November 2009
					
  
Work under this contract will include generation of HIV vaccine
candidates, generation of a universal flu vaccine candidate, process
and assay development for manufacture of vaccine candidates for
clinical testing, and continued support of the HIV vaccine candidates
currently in clinical testing.
  SOURCE:
GenVec, Inc.




  HIV drug study needs volunteers with dark hair
  Treatment Friday 06 November 2009
					
  
Wanted: Dark-haired HIV-negative men and women to participate in a study designed to measure drug levels in hair.
  SOURCE:
SFGate




  EU struggles to curb hard drugs 
  EU Policy Friday 06 November 2009
					
  
European efforts to curb cocaine and heroin use made little impact in
the past year, the EU's main drugs watchdog says in its annual report.
  SOURCE:
BBC News




  Slowed funding imperils AIDS treatment in developing world, report says
  World Policy Friday 06 November 2009
					
  
Slowed funding from international donors, including the United States,
is imperiling recent dramatic gains in treating AIDS patients in the
developing world, according to a new report. 
  SOURCE:
The Washington Post




  No heart rhythm problem with 25 mg of rilpivirine
  Treatment Thursday 05 November 2009
					
  
The low 25 mg dose, which showed evidence of being effective in a Phase
II study involving first-time treatment takers, did not appear to cause
QT interval abnormalities. 
  SOURCE:
AIDSmeds.com




  Reassurance for HIV-positive women about short-term risk of bone loss 
  Treatment Thursday 05 November 2009
					
  
Short-term rates of bone loss are similar in younger HIV-positive and
HIV-negative women, US investigators report in a study published in the
online edition of the Journal of Acquired Immune Deficiency Syndromes.
  SOURCE:
Aidsmap




  Circumcision protects gay men who have a 'preference' for insertive sex from HIV 
  MSM Thursday 05 November 2009
					
  
Circumcision may protect gay men who are exclusively insertive for anal
sex from infection with HIV, an Australian study published in the
November 13th edition of AIDS suggests. 
  SOURCE:
Aidsmap


----------------------------------------------------
DISCLAIMER
The articles in this digest represent a diversity of opinions on topics
of interest to the HIV treatment activist community. The EATG is not
responsible for their content. The articles posted in this digest do
not necessarily reflect EATG views or opinions.
FAIR USE NOTICE
The digest may contain copyrighted material which has not always been
specifically authorised by the copyright owner. Such material is made
available for educational purposes to advance the understanding of
scientific, ethical, legal and social issues. It is believed that this
constitutes a 'fair use' of any such copyrighted material. This
material is distributed without profit.


 

Information in this digest was accurately quoted during its compilation.



__________________________________________________
Do You Yahoo!?
Tired of spam?  Yahoo! Mail has the best spam protection around 
http://mail.yahoo.com 
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mail.eatg.org/pipermail/eatg-forum_eatg.org/attachments/20091105/14090b81/attachment.html>